A 24/7 Wall Street Reader Guide • Free
The Top 10 Stocks to Buy Right Now
Ten names the data says deserve your money this month
- One billionaire just put 66.81% of his US equity portfolio into a single chipmaker.
- A $1.5 billion acquisition for a firm with just $22 million in quarterly revenue hints at precision oncology.
- One monthly dividend payer has never cut its payout since IPO, yielding above 7%.
- A 7.3% single day drop in a memory chipmaker may be an entry point or a warning sign.